tiprankstipranks
Trending News
More News >
GenusPlus Group Ltd. (AU:GNP)
ASX:GNP
Australian Market

GenusPlus Group Ltd. (GNP) AI Stock Analysis

Compare
28 Followers

Top Page

AU:GNP

GenusPlus Group Ltd.

(Sydney:GNP)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
AU$8.50
â–²(17.40% Upside)
GenusPlus Group Ltd. demonstrates strong financial performance with robust revenue and profit growth, efficient operations, and solid cash flow generation. The technical analysis indicates positive momentum, although the stock may be overbought. The valuation suggests potential overvaluation with a high P/E ratio and modest dividend yield. Overall, the company is well-positioned in its industry, but investors should be cautious of the current valuation.
Positive Factors
Cash generation
Sustained, high free cash flow growth and strong cash conversion demonstrate durable internal funding for working capital, bid bonds and capex. This reduces reliance on external finance, supports reinvestment in projects and maintenance contracts, and underpins resilience during project seasonality.
High gross margins
Very high gross margins indicate the company captures material value in design-and-build and bundled services, creating pricing leverage. Healthy operating margins show efficient project delivery and cost control, supporting sustainable profitability if execution disciplines and mix persist.
Prudent leverage and strong ROE
A moderate debt-to-equity ratio and double-digit ROE signal conservative balance sheet management and efficient use of capital. This structural strength provides capacity to bid larger projects, fund growth initiatives and absorb timing differences in project cashflows without undermining solvency.
Negative Factors
Project-based execution risk
Heavy reliance on project-based contracting creates durable exposure to execution risk, scope changes and claims. Profitability hinges on accurate estimating and subcontractor/labour management; persistent delivery issues or cost inflation can materially compress margins and cash conversion over months.
Thin net margins
A wide gap between very high gross margin and low net margin suggests significant operating, overhead or subcontractor cost pass-throughs. This structural margin compression leaves limited buffer against input cost inflation or competitive pricing, making earnings sensitive to project mix shifts.
Rising debt trend
An observable increase in debt, even from modest levels, raises structural interest and refinancing risk if project cashflows slow. Higher leverage can constrain bidding flexibility and elevate breakeven requirements for new contracts during downturns or when working capital needs spike.

GenusPlus Group Ltd. (GNP) vs. iShares MSCI Australia ETF (EWA)

GenusPlus Group Ltd. Business Overview & Revenue Model

Company DescriptionGenusPlus Group Limited engages in the installation, construction, and maintenance of power and communication systems in Australia. The company operates through three segments: Power Services, Telecommunications, and Industrial Services. It offers various services, including planning, designing, constructing, operating, testing, maintaining, managing, and decommissioning power network assets for electricity utilities, infrastructure developers, telecommunications networks, and mining companies. The company also provides electrical and instrumentation, and mechanical services to mining, oil and gas, infrastructure, and power generation sectors; and turnkey communications solutions, such as feasibility, engineering design, site acquisition, logistics, procurement, construction, and integration. GenusPlus Group Limited was incorporated in 2017 and is headquartered in Belmont, Australia.
How the Company Makes MoneyGenusPlus Group Ltd. generates revenue through multiple streams, primarily derived from service contracts in engineering and project management within the energy and resources sectors. Key revenue streams include project-based work, ongoing maintenance contracts, and consultancy services provided to clients. The company also benefits from strategic partnerships with major industry players, allowing them to secure long-term contracts and expand their market reach. Additionally, GNP may derive income from the sale of specialized equipment and technology solutions, further diversifying its revenue portfolio.

GenusPlus Group Ltd. Financial Statement Overview

Summary
GenusPlus Group Ltd. exhibits strong financial health across all verticals. The income statement reflects significant revenue and profit growth, supported by efficient operations. The balance sheet is stable with manageable leverage and strong returns on equity. Cash flow generation is robust, providing a solid foundation for future growth and investment.
Income Statement
85
Very Positive
GenusPlus Group Ltd. has demonstrated strong revenue growth with an 18.48% increase in the latest year, supported by a robust gross profit margin of 76.94%. The net profit margin improved to 4.71%, indicating enhanced profitability. EBIT and EBITDA margins are healthy at 6.65% and 7.59%, respectively, showing efficient operational management. The company has consistently improved its revenue and profit margins over the years, reflecting a positive growth trajectory.
Balance Sheet
78
Positive
The company's balance sheet is stable with a manageable debt-to-equity ratio of 0.32, indicating prudent leverage. Return on equity is strong at 22.14%, showcasing effective use of shareholder funds. The equity ratio stands at 33.92%, reflecting a solid equity base. While the company has increased its debt, the overall financial position remains sound, supporting future growth.
Cash Flow
82
Very Positive
GenusPlus Group Ltd. has shown impressive free cash flow growth of 54.61%, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.21, highlighting efficient cash conversion. The free cash flow to net income ratio of 0.89 further underscores the company's ability to generate cash relative to its earnings. The cash flow position is robust, supporting ongoing operations and potential investments.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue751.27M751.27M551.19M444.18M451.15M318.21M
Gross Profit578.05M578.05M400.06M43.54M311.85M221.55M
EBITDA56.98M56.98M43.11M32.50M32.54M27.28M
Net Income35.37M35.37M19.26M13.41M13.56M13.35M
Balance Sheet
Total Assets470.97M470.97M288.15M227.42M231.98M155.56M
Cash, Cash Equivalents and Short-Term Investments94.32M94.32M100.97M46.74M27.88M34.18M
Total Debt51.74M51.74M29.25M27.73M27.17M19.88M
Total Liabilities311.19M311.19M166.98M122.44M138.56M97.85M
Stockholders Equity159.78M159.78M121.17M104.98M93.42M57.71M
Cash Flow
Free Cash Flow107.82M107.82M68.90M32.09M6.60M-4.30M
Operating Cash Flow120.93M120.93M82.84M37.79M11.47M6.99M
Investing Cash Flow-46.36M-46.36M-15.82M-7.31M-24.25M-12.42M
Financing Cash Flow-16.21M-14.72M-12.79M-11.48M6.33M-189.08K

GenusPlus Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price7.24
Price Trends
50DMA
6.63
Positive
100DMA
6.42
Positive
200DMA
5.19
Positive
Market Momentum
MACD
0.31
Positive
RSI
52.83
Neutral
STOCH
42.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:GNP, the sentiment is Positive. The current price of 7.24 is above the 20-day moving average (MA) of 7.21, above the 50-day MA of 6.63, and above the 200-day MA of 5.19, indicating a bullish trend. The MACD of 0.31 indicates Positive momentum. The RSI at 52.83 is Neutral, neither overbought nor oversold. The STOCH value of 42.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:GNP.

GenusPlus Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
AU$1.41B39.2625.18%0.57%36.30%82.20%
71
Outperform
AU$757.26M21.8050.61%5.24%12.96%8.19%
69
Neutral
AU$828.14M19.418.35%4.17%-21.57%-34.09%
66
Neutral
AU$1.90B37.6913.62%1.85%23.76%21.18%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:GNP
GenusPlus Group Ltd.
7.24
4.51
165.20%
AU:SRG
SRG Global Limited
2.94
1.53
108.51%
AU:GNG
GR Engineering Services Ltd
4.23
1.51
55.51%
AU:CVL
Civmec Singapore Limited Shs Chess Deposit Interests Repr 1 Sh
1.63
0.38
30.63%

GenusPlus Group Ltd. Corporate Events

GenusPlus Lifts FY2026 Earnings Guidance on Strong Segment Performance
Jan 22, 2026

GenusPlus Group Ltd has upgraded its earnings guidance for FY2026, forecasting normalised EBITDA growth of about 35% compared with the prior year’s $67.4 million, following stronger-than-expected unaudited results in its Energy & Engineering and Services segments and solid performance in Infrastructure. Management cites recent contract wins, contributions from acquisitions, a strong order book and favourable industry tailwinds linked to the national energy transition as reinforcing confidence in the company’s growth trajectory and resilience, signalling a positive outlook for shareholders and other stakeholders.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$8.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Issues New Unquoted Performance Rights Under Employee Incentive Scheme
Dec 24, 2025

GenusPlus Group Ltd has issued 396,721 new unquoted performance rights under its employee incentive scheme, with an expiry date of 1 July 2029. The move underscores the company’s continued use of equity-based incentives to align employees’ interests with long-term shareholder value, potentially strengthening staff retention and engagement without immediate dilution of quoted share capital.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Grants 396,721 Performance Rights Under Long-Term Incentive Plan
Dec 24, 2025

GenusPlus Group Ltd has issued 396,721 performance rights to key management personnel and employees under its Employee Securities Incentive Plan, reinforcing its use of equity-linked incentives to align staff rewards with long-term shareholder outcomes. The rights, granted for no upfront consideration, are subject to performance hurdles based on absolute total shareholder return between July 2025 and June 2028 and continued employment, and may be settled either in shares or cash at the board’s discretion, a structure that could impact future dilution and remuneration outcomes while tying executive incentives closely to the company’s market performance.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Seeks ASX Quotation for New Employee Incentive Shares
Dec 23, 2025

GenusPlus Group Ltd has applied to the ASX for quotation of 62,240 new fully paid ordinary shares under its employee incentive scheme. The newly issued securities are not subject to transfer restrictions, indicating the company is continuing to use equity-based remuneration to incentivise staff and align employee interests with shareholder value, although the small number of shares suggests a limited impact on overall capital structure.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Secures A$429m Syndicated Facility to Fuel Growth
Dec 19, 2025

GenusPlus Group Ltd has secured a new A$429 million secured revolving syndicated facility with Commonwealth Bank of Australia, HSBC and National Australia Bank, replacing its previous A$147 million club facility. The three-year multi-option facility significantly expands the company’s funding capacity, providing greater financial flexibility to support its ongoing growth strategy amid favourable industry conditions, and, together with existing surety bond facilities, creates substantial headroom for future expansion and capital needs.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus to Begin Construction on $140M Renewable Energy Project
Dec 17, 2025

GenusPlus Group Ltd has confirmed the commencement of construction for the Hunter-Central Coast Renewable Energy Zone sub-transmission line works, following the execution of a Project Deed with Ausgrid and the Energy Corporation of New South Wales. The contract, valued at approximately $140 million, involves significant infrastructure upgrades, including the demolition and construction of sub-transmission lines and the installation of advanced communication cables, with completion expected by Q1 2028. This project positions GenusPlus as a key player in supporting renewable energy infrastructure in Australia.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$7.50 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Secures Major Contract for Western Renewables Link Project
Dec 12, 2025

GenusPlus Group Ltd, in partnership with ACCIONA, has been awarded a significant contract by AusNet to construct the Western Renewables Link in Victoria, valued at approximately AUD$1.6 billion. This project, which aims to enhance Victoria’s renewable energy infrastructure, will involve the construction of a 500 kV transmission line and is expected to generate substantial economic and community benefits, including job creation and long-term advantages for the local economy.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Announces Director’s Interest Change
Dec 1, 2025

GenusPlus Group Ltd. has announced a change in the director’s interest notice involving David William Riches. The change involves the acquisition of 357,277 fully paid ordinary shares valued at $1,800,000 as contingent consideration for the acquisition of shares in Partum Engineering Pty Ltd. This transaction reflects a strategic move by GenusPlus to consolidate its interests, potentially impacting its operational dynamics and stakeholder relationships.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Releases Shares from Escrow Post-Acquisition
Dec 1, 2025

GenusPlus Group Ltd announced the release of 2,460,937 fully paid ordinary shares from voluntary escrow, linked to its acquisition of Partum Engineering Pty Ltd. This release signifies a strategic move following the acquisition, with 357,277 shares remaining under escrow until December 2026, potentially impacting shareholder value and market perception.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd Announces Quotation of New Securities on ASX
Dec 1, 2025

GenusPlus Group Ltd has announced the quotation of 357,277 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 1, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing additional liquidity for stakeholders.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd Appoints New Director with No Current Securities Interests
Nov 25, 2025

GenusPlus Group Ltd has announced the appointment of Tony Narvaez as a director, effective from November 21, 2025. The Initial Director’s Interest Notice reveals that Tony Narvaez currently holds no relevant interests in securities, either as a registered holder or otherwise, and has no interests in contracts related to the company. This announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in its governance practices.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd. AGM Results: Key Resolutions Passed
Nov 20, 2025

GenusPlus Group Ltd. held its Annual General Meeting on November 20, 2025, where several key resolutions were voted on. The meeting resulted in the approval of the remuneration report, the re-election of director Simon High, and the issuance of contingent consideration shares to David Riches and Matthew Riches under the Partum transaction. These outcomes reflect strong shareholder support for the company’s current management and strategic direction.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Reports Record Year and Strategic Board Addition at 2025 AGM
Nov 20, 2025

GenusPlus Group Ltd held its 2025 Annual General Meeting, highlighting a record year with a Total Shareholder Return of 101% and a significant increase in cash position. The company announced the addition of Tony Narvaez to its board, whose expertise in energy and infrastructure is expected to enhance the company’s strategic direction and strengthen its ability to deliver long-term value.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd Appoints Tony Narvaez as Non-Executive Director
Nov 19, 2025

GenusPlus Group Ltd has appointed Tony Narvaez as a Non-Executive Independent Director, effective November 21, 2025. With extensive experience in the energy sector, including leadership roles at AusNet Services and other major energy companies, Narvaez is expected to bring valuable insights to GenusPlus. His appointment is anticipated to bolster the company’s strategic direction in the energy and infrastructure sectors, particularly as the industry undergoes rapid transformation with increasing opportunities in renewables and advanced technologies.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd. Issues New Securities for Quotation
Nov 10, 2025

GenusPlus Group Ltd. has announced the issuance of 131,207 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX). This move, part of an employee incentive scheme, reflects the company’s strategy to enhance employee engagement and align their interests with shareholders. The issuance may strengthen GenusPlus Group’s market position by potentially increasing liquidity and demonstrating a commitment to rewarding its workforce.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

GenusPlus Group Ltd Announces Cessation of Securities
Nov 7, 2025

GenusPlus Group Ltd has announced the cessation of certain securities, specifically 93,376 performance rights and 99,708 share appreciation rights. These securities have lapsed due to the conditions not being met or becoming incapable of being satisfied, which may impact the company’s capital structure and investor perceptions.

The most recent analyst rating on (AU:GNP) stock is a Buy with a A$6.00 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 25, 2025